LILA visionary.art
Pharmakon Plants Claviceps purpurea
Clavicipitaceae · Hypocreales · Sordariomycetes

Claviceps purpurea

Ergot · rye spur · Mutterkorn · secale cornutum · St Anthony’s fire
Documented relation Cereal pathogen · foodborne ergotism · pharmaceutical source · Ritual hypothesis Eleusinian kykeon · chemically feasible, historically unresolved

Botany

Accepted nameClaviceps purpurea (Fr.) Tul. Elias Magnus Fries described the basionym Sphaeria purpurea; Louis-René Tulasne established the combination in Claviceps in 1853 (Tulasne, 1853; MycoBank, 2026).
Kingdom / phylumFungi · Ascomycota.
FamilyClavicipitaceae.
OrderHypocreales · class Sordariomycetes.
Geographic rangeCosmopolitan across temperate and cool cereal- and grass-growing regions of Europe, Asia, North Africa, the Americas, Australasia and elsewhere. Older records use a broad C. purpurea concept; recent phylogenetic work separates ecological and cryptic lineages, so historic distribution maps partly aggregate several species (Pažoutová et al., 2015; Píchová et al., 2018).
HostsAn obligate ovarian parasite of Poaceae, reported under the broad species concept from more than 400 grass hosts. Rye (Secale cereale) is especially susceptible because its open, cross-pollinating florets expose unfertilised stigmas; triticale, wheat, barley and many forage and seed grasses are also affected, while oats are less commonly infected (Miedaner and Geiger, 2015).
Local namesErgot (French, “spur”); rye spur, horned rye, cockspur; Mutterkorn (“mother grain”), Wolfszahn (“wolf’s tooth”), secale cornutum, cornezuelo del centeno, ergot de seigle. Names encode the sclerotium’s horned form, its association with childbirth and older animal or demonic metaphors.
ConservationNot assessed by the IUCN. It is widespread and managed as a crop pathogen rather than regarded as a threatened fungus. Species splitting complicates statements about the abundance of rarer wetland- and wild-grass-associated relatives.

Morphology and life cycle

The visible “ergot” is a survival body, not a seed or a mushroom: an elongated, hard sclerotium, often 1–4 cm on rye, purple-black outside and whitish within, which replaces a single grain. Fallen sclerotia overwinter at or near the soil surface. After cold conditioning they germinate in spring, raising stalked stromata with pink, red-brown or violet globose heads. Perithecia embedded in each head produce cylindrical asci and threadlike ascospores that are discharged when susceptible grasses flower (Miedaner and Geiger, 2015; Dung et al., 2021).

An ascospore germinates on an unfertilised stigma and follows the route ordinarily taken by a pollen tube into the ovary. Fungal tissue replaces the developing kernel while preserving access to host vascular supply. During the sphacelial phase the infected floret exudes sugary honeydew packed with conidia; rain splash, contact and insects distribute this secondary inoculum. The tissue then hardens and accumulates lipids, pigments and alkaloids as a mature sclerotium. Its resemblance to a grain permits entry into harvests; its larger, lighter body also enables removal by modern optical and density sorting.

Taxonomic and evolutionary limits

Species complex

Molecular work divided the former G1, G2 and G3 populations and recognised taxa including C. purpurea sensu stricto, C. humidiphila and C. arundinis. Most agricultural rye ergot belongs to the broadly distributed G1/sensu-stricto lineage; old vouchers and historical outbreaks usually cannot be reassigned (Pažoutová et al., 2015).

Genome

Comparative genomics reveals a large accessory genome and frequent recombination, features that may support a broad host range and rapid adaptation. Chromosome-level assemblies nevertheless recover eight conserved chromosomes with strain-level rearrangements (Wyka et al., 2022; Witte et al., 2023).

Range history

The modern cosmopolitan distribution follows both wild Pooideae and transported cereal agriculture. A present-day occurrence can therefore reflect old biogeography, crop movement or local wild-grass reservoirs rather than a single expansion event.

Ancient identity

Archaeological sclerotia are morphologically assignable to ergot but rarely preserve the molecular resolution needed to distinguish modern cryptic taxa. “C. purpurea” in ancient contexts normally means the historical rye-ergot complex.

Chemistry

The sclerotium produces a chemotype-dependent mixture of indole-derived ergot alkaloids. Three overlapping classes matter: clavines such as agroclavine and elymoclavine; simple lysergic acid amides, especially ergometrine/ergonovine; and cyclic peptide alkaloids or ergopeptines, including ergotamine, ergocristine, ergocornine, ergosine and α/β-ergocryptine. Each pharmacologically active C-8-(R) form can epimerise to a corresponding “-inine” C-8-(S) form during storage, extraction or analysis. Genotype, host, weather, maturity and handling all change the profile; the mass of visible sclerotia is therefore an imperfect proxy for total alkaloids (Florea, Panaccione and Schardl, 2017; Cherewyk et al., 2024).

Ergotamine

C₃₃H₃₅N₅O₅
Ergopeptine · lysergic acid–tripeptide cyclol
Persistent vasoconstrictor · historic migraine drug

Ergometrine / ergonovine

C₁₉H₂₃N₃O₂
Simple lysergic acid amide
Uterotonic · central activity at sufficient exposure

Ergocristine

C₃₅H₃₉N₅O₅
Ergopeptine alkaloid
Major in some chemotypes · regulated analytical congener

Ergine / LSA

C₁₆H₁₇N₃O
Lysergic acid amide
Usually minor in raw sclerotia · central to processed-kykeon hypothesis

Biosynthesis and receptor pharmacology

Dimethylallyltryptophan synthase, encoded by dmaW, joins tryptophan and dimethylallyl diphosphate at the first committed step. A clustered pathway proceeds through chanoclavine, agroclavine and lysergic acid; lineage-specific non-ribosomal peptide synthetases then assemble ergopeptines. Variation and loss within this cluster generate divergent toxin profiles among strains (Hicks et al., 2021). Ergot alkaloids share an ergoline scaffold able to engage serotonin, dopamine and α-adrenergic receptors, but each ligand has a distinct pattern of agonism, partial agonism and antagonism. Vasoconstriction, uterine contraction and central excitation are consequently distributed unevenly across the mixture (Schiff, 2006; Florea, Panaccione and Schardl, 2017).

Chemical distinctions

Natural mixture

Raw C. purpurea contains ergot alkaloids; it does not naturally contain LSD. LSD-25 is a laboratory diethylamide first synthesised by Albert Hofmann in 1938 from the ergot-alkaloid research programme at Sandoz.

Epimerisation

“Inine” epimers are not interchangeable analytical duplicates. Their abundance can rise after heat, light, pH change and storage, complicating retrospective pharmacology and food monitoring (Cherewyk et al., 2024).

Ergochromes

Yellow and red dimeric xanthone pigments—ergochromes—co-occur with alkaloids and contribute another incompletely resolved toxicological layer (Flieger et al., 2019).

Alkaline transformation

A 2026 laboratory study refluxed identified sclerotia in strongly alkaline solution and generated LSA and iso-LSA after hydrolysis of ergopeptines. It establishes chemical feasibility under the reported conditions; it does not establish an ancient recipe, dose or use at Eleusis (Antonopoulos et al., 2026).

Tradition, ritual & cultural use

Oldest evidenced or proposed human use

Archaeobotanical presenceContamination evidence Ergot sclerotia occur in archaeological cereal deposits. Presence demonstrates a crop–fungus relation; without contextual or residue evidence it does not establish purposeful ingestion or ritual use.
Mas Castellar de PontósRitual-context ingestion At the Iberian site near Greek Emporion, ergot fragments were reported from a small vessel in a Demeter-and-Kore sanctuary and from the dental calculus of an adult male. The find links ergot, ingestion and a cultic setting in the fourth–second centuries BCE, but it is not Eleusis and does not by itself specify a beverage recipe or desired effect (Juan-Tresserras, 2002; Antonopoulos et al., 2026).
Eleusinian textual recordBarley kykeon The Homeric Hymn to Demeter has Demeter refuse wine and request a mixture of water, barley meal and glechon, usually identified as pennyroyal. Ergot is not named. The rites later joined fasting, procession, initiation and the kykeon within the Demeter–Persephone mystery cult (Foley, 1994; Mylonas, 1961).
Ergot–kykeon theoryUnresolved hypothesis Wasson, Hofmann and Ruck proposed in 1978 that selected or processed cereal ergot supplied a psychoactive lysergamide. Archaeological context and the 2026 hydrolysis experiment strengthen plausibility, while the lack of securely identified ergot residues from Eleusis, an ancient procedure or dose prevents confirmation (Wasson, Hofmann and Ruck, 1978; Antonopoulos et al., 2026).
Medieval epidemicsFoodborne affliction From the early medieval period into modernity, outbreaks clustered where rye was a dietary staple and damp conditions favoured infection. Chroniclers called syndromes ignis sacer, mal des ardents and holy fire. Retrospective attribution is strongest where burning limbs, dry gangrene or convulsions accompany contaminated grain; “holy fire” was not a single diagnosis in every source (Eadie, 2003; Grzybowski et al., 2021).
Obstetric drugMedical tradition The vernacular “mother grain” records a long association with childbirth. Early modern and nineteenth-century midwives and physicians used crude ergot to intensify uterine contractions or control postpartum bleeding; John Stearns publicised “pulvis parturiens” in 1808. Variable alkaloid content made crude preparations difficult to govern (Lee, 2009a; Smakosz et al., 2021).

Cultural formations

Retrospective diagnoses and their limits

Salem, 1692

Caporael proposed that ergot-contaminated rye caused the accusers’ symptoms. Spanos and Gottlieb argued that symptom distribution, duration and social performance do not fit a single toxic epidemic. The hypothesis remains culturally influential and historically unproven (Caporael, 1976; Spanos and Gottlieb, 1976).

Pont-Saint-Esprit, 1951

Gabbai and colleagues diagnosed ergot poisoning after a bread-associated outbreak with gastrointestinal, vascular and hallucinatory crises. Later analyses proposed mercury-treated seed, other mycotoxins or adulteration. It is a major modern account of “cursed bread,” but its agent remains disputed (Gabbai, Lisbonne and Pourquier, 1951; Kaplan, 2008).

Witchcraft generally

Ergotism can produce states that observers might interpret through witchcraft or possession. This pharmacological possibility cannot retrospectively explain heterogeneous accusations, trials and religious movements without local dietary, climatic and symptom evidence.

Cosmology & key terms

Grain, death and return

Eleusinian cosmology is agricultural without being reducible to agriculture. Persephone passes between the upper world and Hades; Demeter’s withdrawal suspends fertility; negotiated return restores grain and establishes ritual. Barley meal in the kykeon, first fruits offered to the goddesses and the grain ear shown in later testimonia made cultivation a medium for thinking about bereavement, continuity and death. The ergot hypothesis gains symbolic force because the fungus becomes a dark body in place of grain, but no ancient source states that this substitution was itself a cultic metaphor. That interpretation is modern and should not be smuggled into the evidence (Foley, 1994; Clinton, 2007).

Fire, saint and diseased body

In Latin-Christian Europe, burning pain became ignis sacer and later St Anthony’s fire. Anthony the Great—desert ascetic, adversary of demons and patron of sufferers—offered a cosmological frame for spasms, altered perception and bodily disintegration. Antonine houses made that frame architectural and practical. The sick encountered reliquaries, the Tau sign, bells and pigs as well as beds, food and surgery. The association did not arise because Anthony caused the disease: his cult supplied a patron, institutions and an image-world through which affliction could be endured and treated (Grzybowski et al., 2021).

Art made for the afflicted

Matthias Grünewald’s Isenheim Altarpiece was commissioned for the Antonine hospital at Isenheim and addressed viewers living with severe disease. Its crucified Christ bears a tormented, marked body; the Temptation of Saint Anthony crowds the saint with hybrid attackers and includes a swollen, ulcerated figure. Art historians relate these bodies to the hospital’s patients and its healing programme, while cautioning that the imagery combines several diseases, scriptural exegesis and monstrous convention rather than providing a clinical plate of ergotism. Opened and closed around the liturgical calendar, the altarpiece transformed pain into an itinerary of Passion, temptation, music, resurrection and hoped-for restoration.

“I have fasted; I have drunk the kykeon.”
Initiatory formula reported by Clement of Alexandria; evidence for ritual sequence, not for the drink’s hidden ingredient (Mylonas, 1961).

Material lexicon

Ergot sclerotiumA horn, spur, tooth, abnormal grain and pharmacological raw material; the same object entered mill, apothecary, herbarium and later fermentation laboratory.
Kykeon vesselCup or mixed drink within a ritual sequence. The Mas Castellar vessel is the strongest published cult-context association with ergot; it cannot be treated as an Eleusinian residue sample.
Antonine TauT-shaped cross worn and displayed by the order; a marker of saintly patronage and institutional care.
Pig and bellAntonine pigs enjoyed privileges in some towns and helped support hospitals; bells marked them and also entered the order’s iconography.
Isenheim AltarpieceA polyptych built for an Antonine hospital, joining liturgical transformation to bodies scarred by disease. Its medical relevance is contextual, not diagnostic certainty.

Visionary phenomenology

There is no unitary “ergot experience.” Alkaloid profile, dose, repeated exposure, nutrition and vascular susceptibility divide the historical record into gangrenous, convulsive and mixed syndromes. Much evidence concerns populations eating contaminated staples over days or weeks, not a bounded visionary session. Pharmaceutical exposure and the hypothetical LSA-rich kykeon are still different states. Raw ergot should therefore not be described as natural LSD (Eadie, 2003; Schiff, 2006).

Gangrenous ergotism

Burning · constriction · bodily loss

Cold extremities, pallor or cyanosis, tingling and crawling sensations, loss of peripheral pulse and severe burning pain may progress to dry gangrene, a line of demarcation and auto-amputation. The “fire” is simultaneously sensory and vascular; its phenomenology is of a body becoming painfully alien, rigid, blackened or absent.

Convulsive ergotism

Spasm · delirium · visions

Nausea and vertigo can precede tremor, painful tonic spasms, opisthotonus, seizures, confusion, agitation and hallucinations. Reports include animal presences, persecutory or religious scenes, fugues and impaired reality-testing. These occur within a toxic neurological syndrome rather than a reliably lucid psychedelic field.

Mixed and cumulative exposure

No standard duration

Symptoms can build with repeated contaminated meals and persist for days; vascular injury may be permanent. Regional contrasts between “gangrenous” western and “convulsive” eastern European outbreaks are useful historical patterns, not absolute biological categories.

Hypothetical processed lysergamide

Ancient phenomenology unrecoverable

If an alkaline process generated LSA/iso-LSA, a multi-hour visionary state is chemically conceivable. No ancient dose, concentration, first-person visual description or preparation survives, so duration and intensity cannot be reconstructed from the Eleusinian testimonia.

Accounts and interpretive caution

The 1951 Pont-Saint-Esprit clinicians described episodes of “dreamy delirium” with animal hallucinations and mystical or macabre themes, alongside agitation, bodily symptoms and dangerous behaviour (Gabbai, Lisbonne and Pourquier, 1951). Because the outbreak’s toxic agent is disputed, these accounts are phenomenologically salient but cannot stand as uncontested C. purpurea observations. Medieval chronicles are even harder to translate into modern categories: demonic encounter, sacred fire, convulsion and vision name experiences within theological worlds rather than clinical checklists.

“Dreamy delirium … with animal hallucinations.”
Gabbai, Lisbonne and Pourquier’s clinical description of Pont-Saint-Esprit (1951); causation remains disputed.

Comparative profile

OnsetDietary ergotism may accumulate across repeated meals; acute symptoms can emerge within hours. No historically secure onset is known for an ergot-containing kykeon.
DurationNeurological crises may last hours to days; recurrent exposure prolongs illness; ischaemic damage can be permanent. A discrete 6–12 hour “trip” model does not fit the epidemic evidence.
IntensityRanges from nausea, tingling and anxiety to catastrophic vasospasm, convulsions, delirium, psychosis, gangrene and death, depending on mixture and exposure.
Vision formComplex scenes, animals, persecutors, religious or macabre content and dreamlike confusion are reported in convulsive/toxic states. Eleusinian sources instead emphasise blessedness and knowledge concerning death without giving a visual pharmacography.
Salient distinctionErgotism is a multi-receptor toxic syndrome. LSD is a defined synthetic compound; LSA is a simpler lysergamide; Eleusinian initiation was a ritual institution. Chemical kinship does not make these experiences identical.

Contemporary status

Conservation, agriculture and economies

C. purpurea is neither IUCN-listed nor scarce. Its contemporary economy is divided between exclusion and cultivation: grain systems spend on resistant or pollen-rich cultivars, crop rotation, mowing of grass margins, tillage, cleaning, optical sorting and chemical analysis, while pharmaceutical biotechnology maintains selected ergot strains for alkaloid production in controlled fermentation. The global costs attributable to this species alone are not reliably separable from other ergots, livestock losses and quality downgrades. Climate-sensitive flowering synchrony and wet weather continue to make rye, hybrid rye, wheat, triticale and grass-seed systems vulnerable (Miedaner and Geiger, 2015).

Food and precursor regulation

European Union food lawRegulation (EU) 2023/915 sets maximum levels for visible ergot sclerotia and for the lower-bound sum of six principal alkaloids plus their epimers in specified cereal foods. Regulation (EU) 2024/1808 amended application dates for lower levels in rye and some milling products. These are contaminant limits, not drug scheduling (European Commission, 2023; 2024).
EFSA health valuesThe 2012 CONTAM opinion established a group acute reference dose of 1 μg/kg body weight and a group tolerable daily intake of 0.6 μg/kg for ergot alkaloids. A 2024 update reassessed risks in animal feed and retained concern for several livestock groups (EFSA CONTAM Panel, 2012; 2024).
International precursor controlErgometrine, ergotamine and lysergic acid are Table I substances under the 1988 UN Convention against Illicit Traffic. The control addresses diversion into illicit synthesis; it does not classify the fungus as a scheduled narcotic (INCB, 2025).
United StatesErgonovine/ergometrine, ergotamine and ergocristine are DEA List I chemicals. Lysergic acid and lysergic acid amide are Schedule III controlled substances; LSD is Schedule I. The species and ordinary cereal infection are not themselves scheduled (eCFR, 2026).

Pharmaceutical afterlives

Ergot-derived and ergoline medicines have included ergotamine and dihydroergotamine for migraine, ergometrine or methylergometrine in obstetrics, bromocriptine and cabergoline as dopamine agonists, and other semi-synthetic agents. Their legal availability and preferred clinical roles differ by jurisdiction and have changed as newer drugs emerged. This is an economy of isolated molecules, semi-synthesis and fermentation rather than a market in vernacular ergot preparations (Haarmann et al., 2009).

Patents and intellectual property

Process claims

Twentieth-century Sandoz and successor patents claimed alkaloid isolation, derivatives, fermentation strains, syntheses and therapeutic compositions. Patentable subject matter lies in processes, compounds, strains and uses—not ownership of C. purpurea as a naturally occurring species or of ancient Eleusinian tradition.

LSD lineage

Historic patents around lysergic acid derivatives belong to modern medicinal chemistry. They should not be cited as evidence that LSD occurs naturally or that an ancient culture possessed the modern compound.

Traditional-knowledge interface

Unlike clearly continuous Indigenous plant traditions, the ergot–kykeon claim lacks a living lineage able to supply a transmitted recipe. Contemporary experimental reconstructions are scholarly hypotheses, not recovered community intellectual property.

Latest research

2026

Experimental kykeon chemistry

UHPLC/Q-TOF-HRMS and NMR showed formation of LSA and iso-LSA during alkaline hydrolysis of modern sclerotia. The study materially advances chemical feasibility while leaving historical use unresolved (Antonopoulos et al., 2026).

2024

Food-chain and epimer research

EFSA updated livestock risk assessment; analytical reviews continued to clarify the biological activity and instability of C-8-S “-inine” epimers (EFSA CONTAM Panel, 2024; Cherewyk et al., 2024).

2022–23

Pangenome and chromosome architecture

Long-read and comparative assemblies identified a large accessory genome, high recombination and chromosomal rearrangements that help explain the pathogen’s adaptive breadth (Wyka et al., 2022; Witte et al., 2023).

2021

Divergent alkaloid clusters

Comparative analysis linked biosynthetic-gene-cluster evolution to distinct sclerotial toxin profiles, tightening the connection between fungal lineage and food toxicology (Hicks et al., 2021).

Bibliography

Harvard style (Cite Them Right) · DOI and stable-record links · 40 sources

Archaeology & history

01 · 13 sources
Caporael, L.R. (1976) ‘Ergotism: the Satan loosed in Salem?’, Science, 192(4234), pp. 21–26. Available at: https://doi.org/10.1126/science.769159.
DOI checked
Open record ↗
Clinton, K. (2007) ‘The Mysteries of Demeter and Kore’, in Ogden, D. (ed.) A Companion to Greek Religion. Oxford: Blackwell, pp. 342–356. Available at: https://doi.org/10.1002/9780470996911.ch23.
DOI checked
Open record ↗
Foley, H.P. (ed.) (1994) The Homeric Hymn to Demeter: Translation, Commentary, and Interpretive Essays. Princeton, NJ: Princeton University Press. Available at: https://doi.org/10.1515/9781400849086.
DOI checked
Open record ↗
Grzybowski, A., Żaba, R., Żaba, C. and Żaba, Z. (2021) ‘Ergotism and Saint Anthony’s fire’, Clinics in Dermatology, 39(6), pp. 1088–1094. Available at: https://doi.org/10.1016/j.clindermatol.2021.07.009.
DOI checked
Open record ↗
Haarmann, T., Rolke, Y., Giesbert, S. and Tudzynski, P. (2009) ‘Ergot: from witchcraft to biotechnology’, Molecular Plant Pathology, 10(4), pp. 563–577. Available at: https://doi.org/10.1111/j.1364-3703.2009.00548.x.
DOI checked
Open record ↗
Hofmann, A. (1980) LSD: My Problem Child—Reflections on Sacred Drugs, Mysticism, and Science. Translated by J. Ott. New York: McGraw-Hill.
chemist’s memoir / no DOI assigned
Kaplan, S.L. (2008) Le Pain maudit: Retour sur la France des années oubliées, 1945–1958. Paris: Fayard.
historical monograph / no DOI assigned
Lee, M.R. (2009a) ‘The history of ergot of rye (Claviceps purpurea) I: from antiquity to 1900’, Journal of the Royal College of Physicians of Edinburgh, 39(2), pp. 179–184. Available at: https://doi.org/10.1177/1478271520093902021.
DOI checked
Open record ↗
Mylonas, G.E. (1961) Eleusis and the Eleusinian Mysteries. Princeton, NJ: Princeton University Press.
archaeological monograph / no DOI assigned
Smakosz, A., Kurzyna, W., Rudko, M. and Dasal, M. (2021) ‘The usage of ergot (Claviceps purpurea (Fr.) Tul.) in obstetrics and gynecology: a historical perspective’, Toxins, 13(7), 492. Available at: https://doi.org/10.3390/toxins13070492.
DOI checked
Open record ↗
Spanos, N.P. and Gottlieb, J. (1976) ‘Ergotism and the Salem Village witch trials’, Science, 194(4272), pp. 1390–1394. Available at: https://doi.org/10.1126/science.795029.
DOI checked
Open record ↗
van Dongen, P.W.J. and de Groot, A.N.J.A. (1995) ‘History of ergot alkaloids from ergotism to ergometrine’, European Journal of Obstetrics & Gynecology and Reproductive Biology, 60(2), pp. 109–116. Available at: https://doi.org/10.1016/0028-2243(95)02034-Z.
DOI checked
Open record ↗
Wasson, R.G., Hofmann, A. and Ruck, C.A.P. (1978) The Road to Eleusis: Unveiling the Secret of the Mysteries. New York: Harcourt Brace Jovanovich.
hypothesis / no DOI assigned

Botany & taxonomy

02 · 12 sources
Dung, J.K.S., Alderman, S.C., Kaur, N. and Walenta, D.L. (2021) ‘Ergot of grasses: disease biology and management’, Phytopathology, 111(10), pp. 1727–1737. Available at: https://doi.org/10.1094/PHYTO-07-20-0289-R.
DOI checked
Open record ↗
Grünewald, M. (1512–1516) The Temptation of Saint Anthony, Isenheim Altarpiece. Colmar: Musée Unterlinden. Public-domain reproduction via Wikimedia Commons.
material culture image
Jacquin, O. (2009) ‘Stromata germinating from a sclerotium of Claviceps purpurea’, photograph via Wikimedia Commons. GFDL / CC BY-SA.
life-cycle image record
Juan-Tresserras, J. (2002) ‘La arqueología de las drogas en la Península Ibérica: una síntesis de las recientes investigaciones arqueobotánicas’, in Fábregas Valcarce, R. (ed.) Os alucinóxenos e a arqueoloxía. Santiago de Compostela: Universidade de Santiago de Compostela, pp. 101–121.
archaeobotanical chapter / no DOI assigned
Malmberg, K. (2019) ‘Rye ergot (Claviceps purpurea)’, photograph via iNaturalist and Wikimedia Commons. CC BY 4.0.
hero image record
Miedaner, T. and Geiger, H.H. (2015) ‘Biology, genetics, and management of ergot (Claviceps spp.) in rye, sorghum, and pearl millet’, Toxins, 7(3), pp. 659–678. Available at: https://doi.org/10.3390/toxins7030659.
DOI checked
Open record ↗
MycoBank (2026) ‘Claviceps purpurea (Fr.) Tul., MycoBank 162059’. Available at: mycobank.org (Accessed: 7 August 2026).
nomenclatural database
Open record ↗
Pažoutová, S., Pešicová, K., Chudíčková, M., Šrůtka, P. and Kolařík, M. (2015) ‘Delimitation of cryptic species inside Claviceps purpurea’, Fungal Biology, 119(1), pp. 7–26. Available at: https://doi.org/10.1016/j.funbio.2014.10.003.
DOI checked
Open record ↗
Píchová, K., Pažoutová, S., Kostovčík, M., Chudíčková, M., Stodůlková, E., Novák, P., Flieger, M., van der Linde, E. and Kolařík, M. (2018) ‘Evolutionary history of ergot with a new infrageneric classification (Hypocreales: Clavicipitaceae: Claviceps)’, Molecular Phylogenetics and Evolution, 123, pp. 73–87. Available at: https://doi.org/10.1016/j.ympev.2018.02.013.
DOI checked
Open record ↗
Tulasne, L.-R. (1853) ‘Mémoire sur l’ergot des Glumacées’, Annales des Sciences Naturelles, Botanique, series 3, 20, pp. 5–56.
accepted combination / no DOI assigned
Witte, T.E. et al. (2023) ‘Chromosome-level draft genome sequences of three isolates of the toxigenic fungus Claviceps purpurea showing structural rearrangements’, Microbiology Resource Announcements, 12(10), e00234-23. Available at: https://doi.org/10.1128/mra.00234-23.
DOI checked
Open record ↗
Wyka, S.A. et al. (2022) ‘A large accessory genome and high recombination rates may contribute to the success of Claviceps purpurea as an agricultural pathogen’, PLOS ONE, 17(2), e0263496. Available at: https://doi.org/10.1371/journal.pone.0263496.
DOI checked
Open record ↗

Chemistry & pharmacology

03 · 6 sources
Antonopoulos, R.K., Dadiotis, E., Ioannidis, K. et al. (2026) ‘Investigating the psychedelic hypothesis of kykeon, the sacred elixir of the Eleusinian Mysteries’, Scientific Reports, 16, 8757. Available at: https://doi.org/10.1038/s41598-026-39568-3.
DOI checked
Open record ↗
Cherewyk, J.E. et al. (2024) ‘The C-8-S-isomers of ergot alkaloids—a review of biological and toxicological activity’, Mycotoxin Research, 40, pp. 1–19. Available at: https://doi.org/10.1007/s12550-023-00507-0.
DOI checked
Open record ↗
Flieger, M., Stodůlková, E., Wyka, S.A. and Kolařík, M. (2019) ‘Ergochromes: heretofore neglected side of ergot toxicity’, Toxins, 11(8), 439. Available at: https://doi.org/10.3390/toxins11080439.
DOI checked
Open record ↗
Florea, S., Panaccione, D.G. and Schardl, C.L. (2017) ‘Ergot alkaloids of the family Clavicipitaceae’, Phytopathology, 107(5), pp. 504–518. Available at: https://doi.org/10.1094/PHYTO-12-16-0435-RVW.
DOI checked
Open record ↗
Hicks, C. et al. (2021) ‘Evolution of the ergot alkaloid biosynthetic gene cluster results in divergent mycotoxin profiles in Claviceps purpurea sclerotia’, Toxins, 13(12), 861. Available at: https://doi.org/10.3390/toxins13120861.
DOI checked
Open record ↗
Schiff, P.L. Jr (2006) ‘Ergot and its alkaloids’, American Journal of Pharmaceutical Education, 70(5), 98. Available at: https://doi.org/10.5688/aj700598.
DOI checked
Open record ↗

Toxicology & safety

04 · 6 sources
EFSA CONTAM Panel (2012) ‘Scientific opinion on ergot alkaloids in food and feed’, EFSA Journal, 10(7), 2798. Available at: https://doi.org/10.2903/j.efsa.2012.2798.
DOI checked
Open record ↗
EFSA CONTAM Panel (2024) ‘Risks for animal health related to the presence of ergot alkaloids in feed’, EFSA Journal, 22(1), 8496. Available at: https://doi.org/10.2903/j.efsa.2024.8496.
DOI checked
Open record ↗
Electronic Code of Federal Regulations (eCFR) (2026) ‘21 CFR §1308.13 and §1310.02: Schedule III substances and List I chemicals’. Available at: ecfr.gov (Accessed: 7 August 2026).
US primary law
Open record ↗
European Commission (2023) ‘Commission Regulation (EU) 2023/915 of 25 April 2023 on maximum levels for certain contaminants in food’, Official Journal of the European Union, L119, pp. 103–157. Available at: EUR-Lex (Accessed: 7 August 2026).
primary law
Open record ↗
European Commission (2024) ‘Commission Regulation (EU) 2024/1808 amending Regulation (EU) 2023/915 as regards the application date of lower maximum levels for ergot sclerotia and ergot alkaloids in food’. Available at: EUR-Lex (Accessed: 7 August 2026).
primary law
Open record ↗
International Narcotics Control Board (INCB) (2025) Red List: List of Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances, 23rd edn. Vienna: United Nations. Available at: incb.org.
international control
Open record ↗

Visionary phenomenology

05 · 3 sources
Eadie, M.J. (2003) ‘Convulsive ergotism: epidemics of the serotonin syndrome?’, The Lancet Neurology, 2(7), pp. 429–434. Available at: https://doi.org/10.1016/S1474-4422(03)00439-3.
DOI checked
Open record ↗
Gabbai, Lisbonne and Pourquier (1951) ‘Ergot poisoning at Pont St. Esprit’, British Medical Journal, 2(4732), pp. 650–651. Available at: https://doi.org/10.1136/bmj.2.4732.650.
DOI checked
Open record ↗
Klotz, J.L. (2015) ‘Activities and effects of ergot alkaloids on livestock physiology and production’, Toxins, 7(8), pp. 2801–2821. Available at: https://doi.org/10.3390/toxins7082801.
DOI checked
Open record ↗

Cross-correlations

Eleusinian Kykeon–Mystery ComplexCeremonial complex page: Demeter and Persephone, initiation, kykeon, priesthood, archaeology and competing pharmacological hypotheses. CONTESTED RITUAL ASSOCIATION
Peganum harmalaSpecies monograph: another “ergoline-adjacent” historical candidate only by modern comparison; β-carboline pharmacology and Haoma debates are distinct from ergot. COMPARATIVE HYPOTHESIS
Amanita muscariaSpecies monograph: alternative candidate in some reconstructions of ancient Eurasian sacraments; isoxazole chemistry is unrelated to ergot alkaloids. COMPARATIVE ENTHEOGEN
Papaver somniferumPoppy imagery intersects Demeter cult and ancient medicine, but opiate sedation supplies a different pharmacological and evidential problem. ELEUSINIAN ICONOGRAPHIC ASSOCIATE
Secale cerealeRye is the principal agricultural host and the staple through which European ergotism became historically consequential. HOST PLANT
Hordeum vulgareBarley is named in the Eleusinian kykeon and can host ergot, though less readily than rye. Its ritual presence is documented; ergot contamination is hypothetical at Eleusis. HOST / RITUAL CEREAL
LSD and neo-psychedelicsModern synthetic history emerging from Sandoz ergot chemistry. LSD’s pharmacology and twentieth-century cultures must not be projected backward onto raw ergot or medieval epidemics. CHEMICAL DESCENDANT / MODERN COMPLEX